The biggest stories of the day delivered to your inbox.
– Data support casdozo as a promising novel immuno-oncology agent with clinical activity in liver cancer that may be associated with IL-27 pathway biomarkers – – Data support continued evaluation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results